Navigation Links
‘Land Of Dreams’ Staggers Under The Weight Of Neuroses And Substance Abue
Post Your Comments:
(Date:7/3/2009)...NFORD, Calif. The newest revolution in microbiolog...t,s the hair sheep, a less-hirsute version of the ...m the Stanford University School of Medicine, whic...hat not only are these ruminants low-maintenance a...donors for the microbiology tests necessary to dia...
(Date:7/3/2009)...ROIT, July 3 Ramsy Darwish knows w...medication. In a recent story called America,s "... with CNN,s Rick Sanchez, Ramsy shared his story ...ally ending up at the Narconon Freedom Center ...(Photo 72dpi: Send2Press.com/mediaboom/09-0703-N...
(Date:7/3/2009)...ons drugs may thwart treatment-resistant strain, s...hDay News) -- Extreme drug-resistant tuberculosis ... to treat Parkinson,s disease, suggests a new stud...ersity of California, San Diego, report in the Jul...mercially available entacapone and tolcapone have ...
(Date:7/3/2009)...hers express hope that finding will lead to treatm...s) -- U.S. researchers say they,ve found a major ...elapsed lung cancer. , When caught early, lung ...t detected until the disease is well advanced. Tho...ssion, the disease often springs back more virulen...
Breaking Medicine News(10 mins):Health News:Rare sheep could be key to better diagnostic tests in developing world, says Stanford study 2Health News:Rare sheep could be key to better diagnostic tests in developing world, says Stanford study 3Health News:Narconon Graduate Successfully Recovers From Prescription Drug Abuse 2Health News:New Weapons in Fight Against TB? 2Health News:Cell Pathway May Be Key to Lung Cancer's Spread 2Health News:Cell Pathway May Be Key to Lung Cancer's Spread 3
...300 is used for heart diseases, and prevents the r...re likely to result // in allergic reactions, the...ng to recent studies. The Northwestern Memorial H...d that the use of drug-eluting stent should not be...
...as been devised that can predict the potential att... is that it would help to asthmatics control their... of new drugs. The prediction over the likelihood...over the next month was made by looking at peak fl...
... can now be used to predict the possibility of an ...tool. //It is believed that this finding would hel...ead to the development of better treatment strateg...em called the chaos model (currently applied to co...
... that every patient referral from a GP in England ...system by the end // of this month. But ministers ...for which figures are available - barely 2.7 per c...his way. The Department of Health figures show tha...
Other Medicine News:Health News:Mathematical Model Can Now Help Predict Asthma Risk 2Health News:GP's online referral scheme in UK 'a national IT disaster' 2
(Date:6/29/2009)...Study Seeks to Assess RSV Burden in Outpatient Set...ment to Pediatric Research , , GAITHERSBURG, ...o advance its commitment to pediatric research wit...prospective study designed to assess the burden of...nfants 32-to-35 weeks gestational age (GA) in outp...
(Date:6/29/2009)...or abdominal surgery patients achieved primary and...June 29 AcelRx Pharmaceuticals, In...d Phase 2 clinical study evaluating the safety and...r the management of acute post-operative pain in p...ization. Compared to placebo, patients receiving A...
(Date:6/29/2009)...TON, England, June 29 Vantia Thera...oping novel, small molecule drugs,targeting large...results from,a Phase IIa clinical trial of its le...e trial showed that oral VA106483 was successful i...etic effect in patients, as determined by,increas...
(Date:6/28/2009)...E DO CORONADO, Portugal, June 29 D...at add-on treatment with the novel,once-daily an... ESL) resulted,in a marked and sustained decrease... Results from the one-year extension of a pivot...resented at the International Congress for Epileps...
Breaking Medicine Technology:MedImmune Funds Study to Help Gain Insights Into Full Burden of RSV Disease Among Premature Infants 2AcelRx Announces Positive Phase 2 Results from a Study of ARX-01 Sufentanil NanoTabs in Treating Post-Operative Pain 2AcelRx Announces Positive Phase 2 Results from a Study of ARX-01 Sufentanil NanoTabs in Treating Post-Operative Pain 3AcelRx Announces Positive Phase 2 Results from a Study of ARX-01 Sufentanil NanoTabs in Treating Post-Operative Pain 4Vantia Therapeutics' Lead Candidate VA106483 Demonstrates Positive Anti-diuretic Effect in Phase IIa Trial in Nocturia 2Vantia Therapeutics' Lead Candidate VA106483 Demonstrates Positive Anti-diuretic Effect in Phase IIa Trial in Nocturia 3Data Demonstrates Long-Term Reduction In Seizure Frequency With Novel Once Daily Anti-Epileptic Zebinix(R) 2Data Demonstrates Long-Term Reduction In Seizure Frequency With Novel Once Daily Anti-Epileptic Zebinix(R) 3Data Demonstrates Long-Term Reduction In Seizure Frequency With Novel Once Daily Anti-Epileptic Zebinix(R) 4Data Demonstrates Long-Term Reduction In Seizure Frequency With Novel Once Daily Anti-Epileptic Zebinix(R) 5Data Demonstrates Long-Term Reduction In Seizure Frequency With Novel Once Daily Anti-Epileptic Zebinix(R) 6Data Demonstrates Long-Term Reduction In Seizure Frequency With Novel Once Daily Anti-Epileptic Zebinix(R) 7Mindray to Unveil Three New Products and Reagents at AACC Annual Meeting 24144 1Mindray to Unveil Three New Products and Reagents at AACC Annual Meeting 24144 2Mindray to Unveil Three New Products and Reagents at AACC Annual Meeting 24144 3HistoRx Names Bill Sullivan Senior Vice President Diagnostic Operations 6613 1HistoRx Names Bill Sullivan Senior Vice President Diagnostic Operations 6613 2HistoRx Names Bill Sullivan Senior Vice President Diagnostic Operations 6613 3BioMS Medicals relapsing remitting multiple sclerosis trial receives positive review from Data Safety Monitoring Board 6610 1BioMS Medicals relapsing remitting multiple sclerosis trial receives positive review from Data Safety Monitoring Board 6610 2Cynosure Introduces Affirm CO2 28TM 29 Workstation for Advanced Ablative Therapy 6607 1Cynosure Introduces Affirm CO2 28TM 29 Workstation for Advanced Ablative Therapy 6607 2Cynosure Introduces Affirm CO2 28TM 29 Workstation for Advanced Ablative Therapy 6607 3Cynosure Introduces Affirm CO2 28TM 29 Workstation for Advanced Ablative Therapy 6607 4
...IRE)--Mar 6, 2007 - POZEN Inc.,(NASDAQ: POZN), tod...n" PA 325 proof-of-concept study conducted during ...ormulation of 325mg of,aspirin surrounded by a 20m... proton pump inhibitor., The PA 325, 28 day study,...f 50. Each subject was treated with either once a ...
...LL, N.C., US, March 06, 2007,/PRNewswire/ -- AOP O...io, Inc. ("Lantibio") today announced positive fin...linded Phase II clinical,study of Moli1901, an exp.... Moli1901 is being developed by AOP Orphan in,Eur...ent with,Lantibio. The study, performed at multipl...
Other Medicine Technology:POZEN Announces Positive Outcome for PA 325 Proof of Concept Study 2POZEN Announces Positive Outcome for PA 325 Proof of Concept Study 3AOP Orphan Pharmaceuticals and Lantibio Announce Positive Phase II,Study with Novel Cystic Fibrosis Therapy 2AOP Orphan Pharmaceuticals and Lantibio Announce Positive Phase II,Study with Novel Cystic Fibrosis Therapy 3AOP Orphan Pharmaceuticals and Lantibio Announce Positive Phase II,Study with Novel Cystic Fibrosis Therapy 4
...n (MST) is a surgical technique designed to treat ...rea that cannot be surgically resected without cau... technique, fine parallel cuts are made in the cor... seizure discharge without compromising the vertic...
...s were developed to reproducibly and accurately cr... double bundle PCL reconstruction. The guides simp...teromedial femoral tunnel sockets drilled endoscop...erolateral tunnel placement a guide can be used ei...
...t offers surgeons an alternative to traditional ar...hammertoe deformity. The prosthesis is constructed...ed for the proximal interphalangeal joints of digi...atomic hinge design similar to that used in digita...
The primary objective of the BioPro Toe implant is to provide a durable arthroplasty that will relieve pain and restore motion while leaving the biomechanical arrangement of the foot undisturbed. The
Medicine Products: